For most people, the new coronavirus causes mild or moderate symptoms, which can include fever and cough but sometimes pneumonia requiring hospitalization. The risk of death is greater for older adults and people with other health problems.
In animal tests against SARS and MERS, diseases caused by similar coronaviruses, the drug helped prevent infection and reduced the severity of symptoms when given early enough in the course of illness. It’s farther along in testing than many other potential therapies, and the current studies could lead to regulatory approval.'The patients are quite interested'
In another letter on Saturday, O’Day said the company has 1.5 million doses, which could mean more than 140,000 treatment courses, depending on how long treatment needs to last. The company is providing the drug for free for now and has set a goal of making 500,000 treatment courses by October and more than a million by the end of the year.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: HuffPostWomen - 🏆 27. / 68 Read more »
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: latimes - 🏆 11. / 82 Read more »
Source: NPRHealth - 🏆 144. / 63 Read more »
Source: Mirror Celeb - 🏆 476. / 51 Read more »